Wolverine Trading
LSTA icon

Wolverine Trading’s Lisata Therapeutics LSTA Stock Holding History

Wolverine Trading’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3,080
Closed -$25K – 5018
2022
Q2 		$25K Buy
3,080
+560
+22% +$4.61K ﹤0.01% 4204
2022
Q1 		$29K Buy
+2,520
New +$28.8K ﹤0.01% 5196
2021
Q4 		– Sell
-1,473
Closed -$26K – 6433
2021
Q3 		$26K Buy
+1,473
New +$28.9K ﹤0.01% 6116
2020
Q3 		– Sell
-853
Closed -$23K – 4884
2020
Q2 		$23K Buy
+853
New +$25.1K ﹤0.01% 4423

Other funds holding LSTA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CW
Cook Wealth Raleigh, North Carolina $206M AUM 4.73% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wolverine Trading's LSTA Position: Q4 2021 in Review

Wolverine Trading sold out of Lisata Therapeutics (LSTA) in Q4 2021, closing a stake of 1,735 shares — an estimated $30K sold.

Wolverine Trading first reported a position in LSTA in Q3 2021 and held it in 1 quarter. The position peaked at $30K in Q3 2021. 34 funds tracked by Wall St. Rank hold LSTA as of Q4 2021.

  • Wolverine Trading reported no remaining Lisata Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Wolverine Trading sold 1,735 Lisata Therapeutics shares in Q4 2021, an estimated $30K.
  • Wolverine Trading first reported a position in Lisata Therapeutics in Q3 2021 and held it in 1 quarter.
  • Wolverine Trading's Lisata Therapeutics position peaked at $30K in Q3 2021.
  • 34 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q4 2021.

Based on Wolverine Trading's 13F filing for Q4 2021, filed 14 Feb 2022.